Product NDC: | 11980-022 |
Proprietary Name: | BLEPHAMIDE |
Non Proprietary Name: | sulfacetamide sodium and prednisolone acetate |
Active Ingredient(s): | 2; 100 mg/mL; mg/mL & nbsp; sulfacetamide sodium and prednisolone acetate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SUSPENSION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11980-022 |
Labeler Name: | Allergan, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012813 |
Marketing Category: | NDA |
Start Marketing Date: | 19611001 |
Package NDC: | 11980-022-05 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (11980-022-05) > 5 mL in 1 BOTTLE, DROPPER |
NDC Code | 11980-022-05 |
Proprietary Name | BLEPHAMIDE |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (11980-022-05) > 5 mL in 1 BOTTLE, DROPPER |
Product NDC | 11980-022 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sulfacetamide sodium and prednisolone acetate |
Dosage Form Name | SUSPENSION/ DROPS |
Route Name | OPHTHALMIC |
Start Marketing Date | 19611001 |
Marketing Category Name | NDA |
Labeler Name | Allergan, Inc. |
Substance Name | PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM |
Strength Number | 2; 100 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Sulfonamide Antibacterial [EPC],Sulfonamides [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |